NextCure, Inc.
NextCure, Inc. scores highest on Nitro (48) and lowest on Torque (24). Its PosiPenta is 33.16 out of 100, weaker than most similar companies.
On the Penta Grid this week, NextCure, Inc. is Grid #712 of 837 in the Healthcare sector in United States, and Grid #3,421 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| NextCure, Inc. | 33.16 | 26 | 27 | 48 | 24 | 41 |
| Context Therapeutics Inc. | 37.05 | 45 | 45 | 10 | 57 | 28 |
| Aytu BioPharma, Inc. | 51.96 | 44 | 64 | 58 | 39 | 55 |
| TherapeuticsMD, Inc. | 60.75 | 42 | 87 | 67 | 58 | 50 |
| Seres Therapeutics, Inc. | 30.33 | 43 | 18 | 9 | 26 | 56 |
| Shuttle Pharmaceuticals Holdings, Inc. | 24.38 | 9 | 5 | 22 | 53 | 32 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -0.72 |
| P/B ratio | 2.35 |
EEarnings
| Trailing EPS | ₹-824.97 |
| Forward EPS | ₹-558.34 |
NNitro
| Price | 591.02 |
| 52-week high | 1490.81 |
| 52-week low | 146.81 |
| Fall from 52-week high | 60.4% |
TTorque
| Return on equity (ROE) | -204.56% |
| Debt-to-equity | 0.38 |
AAnchor
| Beta (price swings) | 1.35 |
| Market cap | ₹270 Cr |
| Insider holding | 8.64% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is NextCure, Inc.'s PosiPenta score?
NextCure, Inc.'s PosiPenta is 33.16 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does NextCure, Inc. stand on the Penta Grid?
On the Penta Grid this week, NextCure, Inc. is Grid #712 of 837 in the Healthcare sector in United States, and Grid #3,421 of 4,000 in United States.
Which PosiPenta pillar is strongest for NextCure, Inc.?
Nitro (momentum), with a score of 48 out of 100: around the middle of similar companies.
Which PosiPenta pillar is weakest for NextCure, Inc.?
Torque (durability), with a score of 24 out of 100: weaker than most similar companies.
Has NextCure, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.56 points, from 30.60 to 33.16.
PositoAI is for research and education only and is not investment advice.